CRIS Current Research Information System

LODATO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.004
NA - Nord America 2.790
EU - Europa 2.001
AF - Africa 189
SA - Sud America 84
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 8.072
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.769
VN - Vietnam 1.522
SG - Singapore 599
GB - Regno Unito 546
CN - Cina 510
SE - Svezia 295
DE - Germania 254
IT - Italia 226
HK - Hong Kong 143
UA - Ucraina 113
RU - Federazione Russa 112
IN - India 106
FR - Francia 89
IE - Irlanda 85
NL - Olanda 67
CI - Costa d'Avorio 61
BR - Brasile 59
CH - Svizzera 52
ZA - Sudafrica 46
EE - Estonia 43
TG - Togo 39
KR - Corea 38
FI - Finlandia 29
JP - Giappone 28
JO - Giordania 26
NG - Nigeria 18
BE - Belgio 17
BG - Bulgaria 17
PL - Polonia 16
SC - Seychelles 16
CA - Canada 15
GR - Grecia 15
AR - Argentina 10
IR - Iran 10
ES - Italia 9
BD - Bangladesh 5
EC - Ecuador 5
CZ - Repubblica Ceca 4
LT - Lituania 4
CO - Colombia 3
DZ - Algeria 3
ID - Indonesia 3
MX - Messico 3
SA - Arabia Saudita 3
TR - Turchia 3
AU - Australia 2
DK - Danimarca 2
HR - Croazia 2
KE - Kenya 2
MA - Marocco 2
NO - Norvegia 2
PE - Perù 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BO - Bolivia 1
CL - Cile 1
DM - Dominica 1
EG - Egitto 1
EU - Europa 1
GN - Guinea 1
IL - Israele 1
LB - Libano 1
MY - Malesia 1
NI - Nicaragua 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
TL - Timor Orientale 1
UY - Uruguay 1
UZ - Uzbekistan 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.072
Salva come PNG Salva come JPEG
Città #
Southend 487
Singapore 402
Ho Chi Minh City 341
Chandler 339
Ashburn 314
Hanoi 298
Fairfield 285
Dong Ket 242
Hong Kong 142
Santa Clara 134
Houston 129
Wilmington 110
Woodbridge 103
Ann Arbor 99
Seattle 99
Princeton 93
Dublin 84
Boardman 76
Hefei 74
Cambridge 73
Beijing 70
Jacksonville 68
Abidjan 61
Da Nang 49
Westminster 48
Bern 47
Nanjing 42
Haiphong 39
Lomé 39
Los Angeles 37
Padova 33
Medford 32
Saint Petersburg 32
Ha Long 31
Seoul 31
Thái Nguyên 30
Munich 28
Amman 26
Dallas 26
Quận Bình Thạnh 26
Tokyo 26
Berlin 25
Dearborn 25
Biên Hòa 24
Buffalo 23
Bắc Ninh 20
Bologna 19
Helsinki 19
Hải Dương 19
Abeokuta 18
Can Tho 18
Milan 18
Brussels 17
New York 17
Shenyang 17
Sofia 17
Vinh 17
Bremen 16
Hebei 16
Jinan 16
Ninh Bình 16
Vũng Tàu 16
Florence 15
Nanchang 14
Turin 14
Bắc Giang 12
Guangzhou 12
Changsha 11
Falkenstein 11
Frankfurt am Main 11
Quận Phú Nhuận 11
Falls Church 10
Jiaxing 10
Redondo Beach 10
Shanghai 10
Torino 10
Chicago 9
Mülheim 9
Norwalk 9
Turku 9
Uyen Hung 9
Zhengzhou 9
Council Bluffs 8
Lấp Vò 8
Mahé 8
Nam Định 8
Pune 8
San Diego 8
Toronto 8
Haikou 7
Hangzhou 7
Monmouth Junction 7
Mountain View 7
Quận Bốn 7
Quận Một 7
Redwood City 7
Rome 7
São Paulo 7
Thành Phố Bà Rịa 7
Tianjin 7
Totale 5.486
Salva come PNG Salva come JPEG
Nome #
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence 574
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence 486
Outcomes and survival after TIPS positioning: a single center experience 381
Two cases of severe autoimmune manifestations following virological response to peginterferon alpha- 2b + ribavirin in liver transplanted patients with recurrence of chronic hepatitis C 320
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 260
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 260
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 229
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 226
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 213
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 198
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 195
Adverse effects of proton pump inhibitors. 189
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 184
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 183
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 175
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 168
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 166
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 163
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 160
Pharmacological modulation of MRP2 in primary biliary cirrhosis 152
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 152
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 152
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 148
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 148
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 147
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 145
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 144
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 142
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 141
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 136
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 131
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 130
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 129
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 128
MRP2 is upregulated by UDCA in cholestasis of pregnancy. 126
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 125
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 125
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 125
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 115
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 113
Placental MRP2 is upregulated by UDCA in cholestasis of pregnancy. 112
Modulation of placental bilirubin and bile acids transporters during cholestasis of pregnancy. 111
Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression 104
Outcomes and survival after TIPS positioning: a single center experience 93
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. 89
Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence 87
Impact of multidisciplinary discussion on pancreatic neuroendocrine tumours, experience of a tertiary centre 8
Totale 8.188
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.835
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021527 0 0 0 0 0 21 15 32 72 21 23 343
2021/20221.072 125 49 63 63 76 71 18 48 35 52 283 189
2022/20231.187 122 185 63 155 71 97 31 63 191 30 86 93
2023/2024264 13 45 13 34 19 59 9 13 28 13 9 9
2024/20251.035 45 185 80 56 175 49 47 29 27 85 36 221
2025/20262.229 1.274 225 186 145 327 72 0 0 0 0 0 0
Totale 8.188